FDA Looks Back On Fifty Years of Cannabis Research, Prepares for Growth Ahead

FDA researchers published an article this week titled “From Our Perspective: FDA’s 50 Years of Experience with Cannabis Research Helping to Support Tomorrow’s Cannabis Drug Development.”


House Lawmakers Push Top FDA Official on Hemp Products and Cannabis Rescheduling 

The conversation covered the proliferation of intoxicating hemp products, as well as the timeline for the federal review of whether to move cannabis from Schedule I to III.

New York

New York Cannabis Regulators Celebrate 100-Store Milestone, Forecast Market Changes Ahead

On Thursday, the state’s cannabis regulators talked about pitfalls to avoid as New York’s market matures.